CFG
BSX icon

Carr Financial Group’s Boston Scientific BSX Stock Holding History

Carr Financial Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$256K Sell
6,001
-5,168
-46% -$281K 0.06% 161
2026
Q1 		$701K Buy
11,169
+357
+3% +$28.6K 0.18% 83
2025
Q4 		$1.03M Sell
10,812
-1,048
-9% -$103K 0.27% 62
2025
Q3 		$1.16M Sell
11,860
-613
-5% -$63.5K 0.32% 59
2025
Q2 		$1.34M Buy
+12,473
New +$1.26M 0.4% 48

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Carr Financial Group's BSX Position: Q2 2026 in Review

Carr Financial Group reduced its Boston Scientific (BSX) stake by 46% in Q2 2026, selling an estimated $281K and leaving 6,001 shares worth $256K. The position accounts for 0.06% of the portfolio, ranked #161.

Carr Financial Group first reported a position in BSX in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.34M in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Carr Financial Group held 6,001 shares of Boston Scientific worth $256K as of Q2 2026.
  • Carr Financial Group sold 5,168 Boston Scientific shares in Q2 2026, an estimated $281K.
  • Boston Scientific made up 0.06% of Carr Financial Group's portfolio in Q2 2026, its #161 holding.
  • Carr Financial Group first reported a position in Boston Scientific in Q2 2025 and has held it in 5 quarters since.
  • Carr Financial Group's Boston Scientific position peaked at $1.34M in Q2 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Carr Financial Group's 13F filing for Q2 2026, filed 6 Aug 2026.